Regenstrief and IUPUI researchers use EHRs to identify cancer symptom clusters

October 22, 2019

INDIANAPOLIS - Patients with chronic diseases such as breast cancer or colorectal cancer often experience fatigue, pain, depression and other symptoms which can lead to distress and functional impairment if left untreated. With the ultimate goal of helping clinicians manage and treat symptoms that negatively affect health and quality of life, researchers from the Regenstrief Institute and IUPUI have devised and tested novel methodologies to extract data on symptoms from electronic health records (EHRs) and have successfully investigated associations between symptom clusters and disease.

"Our novel methods can be generalized beyond breast and colorectal cancer to analyze symptom clusters of other chronic diseases where symptom management and treatment is critical," said Regenstrief Institute investigator Kun Huang, PhD, senior author of the study and an internationally recognized leader in translational bioinformatics. "Identifying and understanding symptom clusters -- which symptoms tend to go together - fatigue and depression, for example -- and when these symptoms occur during the course of treatment - provides critical information to a patient's care team, especially as we look forward to precision health and try to find the right treatment for the right patient at the right time.

"This information is also important to researchers as they explore whether biological reasons behind these co-occurrences exist and, if so, determine why," Dr. Huang said. In addition to his appointment as a Regenstrief Institute research scientist, he is assistant dean for data sciences, Precision Health Initiative professor of genomics data sciences and professor of medicine at Indiana School of Medicine.

"Identifying Symptom Clusters in Breast Cancer and Colorectal Cancer Patients using EHR Data," won the Best Paper Award at the 10th Association for Computing Machinery (ACM) Conference on Bioinformatics, Computational Biology and Health Informatics and is published in the conference proceedings. This prestigious prize is presented for a paper that represents groundbreaking research. Through the Best Paper Award, the ACM highlights theoretical and practical innovations likely to shape the future of computing.

Detecting and tracking symptom severity and frequency in an EHR are not easy. Language often varies. For example, fatigue may be recorded in an EHR as listless, exhausted, tired, no energy or worn out. Depression may be indicated as sad, unhappy, hopeless or discouraged. To mitigate the terminology problem, the research team designed methodology to enable the analysis of free text clinical notes in EHRs in addition to extracting information from structured entries in the medical record.

"EHR data has not been extensively used to understand patient-reported symptoms for individuals with chronic diseases," said study author Xiao Luo, Ph.D., assistant professor of computer and information technology in IUPUI's School of Engineering and Technology. "Utilizing EHR data obtained from the Indiana Network for Patient Care, we developed a framework that employs components of data mining, NLP (natural language processing) and machine learning to explore clinical information accumulated throughout the course of these diseases," she said. Dr. Luo, who designed the study's methodology, specializes in predictive data analytics and intelligent data integration.

The researchers looked at symptoms during two time periods - the first year of chemotherapy and the 48 to 54 months following chemotherapy. Age, smoking history and whether the individual had diabetes were also considered. Symptom clusters were identified based on severity and combination of symptoms.

Using algorithms they developed, the researchers found that the symptom clusters were not the same for breast cancer patients and colorectal cancer patients. They also noted varying symptom clusters at different time frames following chemotherapy. Breast cancer patients had slightly more symptoms than colorectal cancer patients during the first year after chemotherapy. Colorectal cancer patients had slightly more depression 48 to 54 months after chemotherapy. The researchers also were able to identify linkages. For example, if a high-stage colorectal cancer patient had no fatigue symptom, he or she was also unlikely to experience depression.

Cancer patients present with multiple, co-occurring symptoms related to the disease and its treatment. "Typically clinicians identify, measure and treat patient's symptoms such as -- fatigue, depression, anxiety -- individually, rather than as co-occurring" said study author Susan Storey, Ph.D., R.N., assistant professor at IU School of Nursing and a member of the Indiana University Melvin and Bren Simon Cancer Center and the Diabetes Translational Research Center. "This new methodology sets us firmly on the path to better understand symptoms, the way they cluster and how they are related to disease outcomes and quality of life. As we expand this work it will have significant implications for patients and the clinicians who treat them because it will help us understand why and how these symptom clusters interact with each other in order to develop strategies to counter them." Dr. Storey has 25 years of experience as an oncology certified advance practice nurse.
-end-
In addition to Drs. Huang, Luo and Storey, study authors are Regenstrief Institute research scientist and IU School of Medicine assistant research professor Zhi Han, Ph.D.; IU School of Medicine assistant scientist Zuoyi Zhang, Ph.D., and School of Science at IUPUI master's degree candidate Priyanka Gandhi.

This work was supported by a Research Investment Funding grant from IU School of Nursing and by IU School of Medicine Precision Health Initiative. The researchers plan to expand the framework they developed and tested to other symptom clusters and chronic diseases.

Regenstrief Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.